Hormone therapy of cryptorchism
Granchelli, D.; Pantaleo, A.
La Clinica Terapeutica 99(4): 397-400
1981
ISSN/ISBN: 0009-9074 PMID: 6118219 Document Number: 181882
The efficacy of hormone treatment using gonadotropins in human cryptorchidism, is stressed.
Document emailed within 1 workday
Related Documents
Günther, E. 1971: Therapy and prognosis of cryptorchism Zeitschrift für Arztliche Fortbildung 65(18): 961-963Fahlenkamp, D.; Raatz, D.; Schönberger, B. 1992: Laparoscopic diagnosis and therapy of cryptorchism Der Urologe. Ausg. a 31(6): 328-332
Genazzani, A.; Gambacciani, M.; Simoncini, T.; Anniverno, R.; Becorpi, A.M.; Biglia, N.; Brandi, M.L.; Guaschino, S.; Lello, S.; Massobrio, M.; Melis, G.B.; Mencacci, C.; Modena, M.G.; Nappi, C.; Nappi, R.E.; Pecorelli, S.; Petraglia, F.; Rosano, G.M.; Serra, G.B.; Sismondi, P.; Taddei, S.; Tonelli, F. 2007: Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 23(8): 436-444
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Orias, R. 1968: Effect of hypothalamic extracts and stress on the pituitary melanocyte stimulating hormone content in rats abstract in vitro rana pipiens skin follicle stimulating hormone luteinizing hormone growth hormone oxytocin hormone vasopressin hormone Proceedings Int Union Physiology Science 7(24): 332
Von Werder, K. 1987: Growth hormone releasing hormone (GRH)--pathophysiology, clinical aspects, therapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 93: 386-394
Collet, P. 2002: Hormone replacement therapy for menopause: continue or stop the prescription after 10 years? Should hormone replacement therapy be continued after 10 years? of course not! Gynecologie Obstetrique and Fertilite 30(9): 736-739
Lauritzen, C. 1979: Hormonal regulation and hormone therapy in childhood and adolescence. Part 1: development of endocrine glands, hormone production, menarche and secondary sex characteristics Fortschritte der Medizin 97(18): 863-868
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Drent, M.L.; Delemarre-van de Waal, H.A.; Wit, J.M. 2002: Once growth hormone, always growth hormone? Transition from growth hormone therapy in childhood to adulthood Nederlands Tijdschrift Voor Geneeskunde 146(4): 154-157
Sharpe R.M. 1979: Modulation of prolactin luteinizing hormone and follicle stimulating hormone secretion by luteinizing hormone releasing hormone and bromocriptine cb 154 in the hypophysectomized pituitary grafted male rat and its effect on testicular luteinizing hormone receptors and testosterone output Biology of Reproduction 21(1): 141-148
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356
Fideleff, H.L.; Boquete, H.; Giaccio, A.; Sobrado, P. 2006: Medium and long-term outcome of growth hormone therapy in growth hormone deficient adults Medicina 66(4): 296-302
Finkenstedt, G.; Höfle, G.; Pallua, A.; Sailer, U.; Gasser, R.W. 1999: Changes in the volume of residual pituitary adenomas in patients with adult-onset growth hormone deficiency during replacement therapy with the recombinant human growth hormone Wiener Klinische Wochenschrift 111(21): 887-890
Nozaki, H.; Funahashi, H.; Sato, Y.; Imai, T.; Oike, E.; Kato, M.; Takagi, H. 1991: Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry Nihon Geka Gakkai Zasshi 92(12): 1700-1707
Yonei, Y.; Takahashi, Y.; Hibino, S. 2007: Hormone replacement Up-to-date. Hormone replacement therapy in anti-aging medicine Clinical Calcium 17(9): 1400-1406
Rannevik, G.; Jeppsson, S.; Kullander, S.; Thorell, J. 1973: Effects of synthetic luteinizing hormone releasing hormone on plasma levels of luteinizing hormone follicle stimulating hormone and thyrotropin in amenorrheic women and comparison of luteinizing hormone and follicle stimulating hormone response after intra venous intra muscular and sublingual administration Acta Endocrinologica Supplementum 177: 293
Bell, J.J.; Dana, K. 1998: Lack of correlation between growth hormone provocative test results and subsequent growth rates during growth hormone therapy Pediatrics 102(2 Pt 3): 518-520
Butenandt, O.; Kiess, W. 1987: Growth hormone secretion following administration of growth hormone releasing hormone in constitutional short stature and idiopathic growth hormone deficiency Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(2): 114-115
Ohta, H. 2007: Hormone replacement Up-to-date. Menopause in women and hormone replacement therapy (HRT). Indications for HRT in postmenopausal women Clinical Calcium 17(9): 1315-1324